How much does metformin cost through a longevity program?

Posted prices for metformin run $25–$169 a month. Rapamycin runs $65–$207 a month. GLP-1 plans cost more, and each pick card shows the provider's own figure.

Can a lower-cost metabolic medicine replace the one my clinician recommends?

Price alone cannot establish a substitute. Metformin, GLP-1 medicines and off-label rapamycin do not have the same approved uses or clinical evidence. Ask what problem the proposed medicine addresses and which alternatives fit that problem. A low-cost aging offer should not be treated as equivalent to an approved diabetes or obesity treatment.

Why are GLP-1 drugs on a metabolic list?

Semaglutide and tirzepatide are approved brand drugs for type 2 diabetes, and people seek them out for blood sugar and weight. A provider selling either one can appear here and on the body-composition list.

Your shortlist for metabolic

By Peptide Clarity Guide · October 2026

Compare medication and care services relevant to metabolic health. GLP-1 medicines, metformin and off-label longevity programs have different approved uses and evidence; the service list does not make them interchangeable responses to a family history or symptom.

All the metabolic providers, In first, then Not yet.

We may earn a commission through qualifying provider links at no extra cost to you. Read our selection criteria and funding disclosure. How we earn

Partners on this list

Partner cards: if you join through one, the provider pays us a fee and your price stays the same. The full list below keeps its pick order.

Strut HealthPartner
Semaglutide injections$130.79/mo
Visit Strut Health Read the pick

Made the shortlist

Listed in pick order. See how picks work.

Top pick
Goldspan Health
Microdose listings need their own formulation and clinical-evidence assessment.
Semaglutide injections$248.76/mo
Visit Goldspan Health
Strut HealthPartner
Compounded semaglutide and tirzepatide with free follow-ups and no membership fee.
Semaglutide injections$130.79/mo
Visit Strut Health
Prime Doctor RX
Daily semaglutide tablets or weekly shots, with prepaid plans that lower the price.
Semaglutide injections$270.49/mo
Visit Prime Doctor RX
AgelessRx
Rapamycin with baseline and ongoing blood work included in the monthly price.
Semaglutide pills$349/mo
Visit AgelessRx
altRx
The product FAQ names network pharmacies; verify the facility assigned to your order.
Semaglutide injections$89/mo
Visit altRx
Precision Telemed
The full tirzepatide program differs from the lower maintenance-only offer.
Semaglutide injections$149.99/mo
Visit Precision Telemed
Luvo Health
Low-dose semaglutide or tirzepatide plans at one 4-week price for either drug.
Semaglutide injections$227.04/mo
Visit Luvo Health
Gala GLP-1Partner
GLP-1 care with a dose log, refill reminders and a care team seven days a week.
Semaglutide injectionsPrice on request
Visit Gala GLP-1
PauseRx
A consult for brand Foundayo, Wegovy or Zepbound, with the drug billed by its maker.
Semaglutide injectionsPrice on request
Visit PauseRx
SnagRx
Month-to-month or prepaid GLP-1 plans, with the visit and shipping in the price.
Semaglutide injections$99/mo
Visit SnagRx
Brightmeds
GLP-1 clinician review is included; confirm monitoring and the complete recurring quote.
Semaglutide injections$129/mo
Visit Brightmeds
HealthRX
Metformin and rapamycin appear in the catalog with separate prescription decisions.
Metformin pills$134/mo
Visit HealthRX
TeleZen MD
The GLP-1 service bundles care and educational programs; outcomes remain individual.
Semaglutide injections$174.72/mo
Visit TeleZen MD
Willow
Compare the exact GLP-1 preparation, dose and renewal amount before enrollment.
Semaglutide injections$299/mo
Visit Willow
Lttl
Microdose options are separately listed rather than assumed equivalent to standard plans.
Semaglutide injectionsPrice on request
Visit Lttl
Collective
Flat-priced GLP-1s plus doctor messaging and dietitian Q&As on a yearly membership.
Semaglutide injections$75.58/mo
Visit Collective
Trimi Health
Weekly GLP-1 shots with every billing term and its full charge printed up front.
Semaglutide injections$175/mo
Visit Trimi Health
CoreAge Rx
Compare the advertised price-lock policy alongside the written renewal agreement.
Semaglutide injectionsPrice shown after a few questions
Visit CoreAge Rx

Not a pick yet

Arc-1 Not yet
Why: Prints no cancellation terms for its monthly subscriptions.
When the gap closes, Arc-1 can move to In.
Read the pick
Bayan Health Not yet
Why: Investigational peptide listings leave the qualifying access pathway unclear.
When the gap closes, Bayan Health can move to In.
Read the pick
Belle Not yet
Why: Confirm the dispensing pharmacy, payment schedule and order-stage refund terms.
When the gap closes, Belle can move to In.
Read the pick
BioGlow Health Not yet
Why: Approximate month-supply prices do not establish automatic refill charges or dates.
When the gap closes, BioGlow Health can move to In.
Read the pick
bmiMD Not yet
Why: Terms describe twenty-eight-to-thirty-day renewal and separate quarterly billing.
When the gap closes, bmiMD can move to In.
Read the pick
Bodybuilding Health+ Not yet
Why: Lists Strive Pharmacy but not which Strive site fills your order.
When the gap closes, Bodybuilding Health+ can move to In.
Read the pick
Defy Medical Not yet
Why: Medication, testing and consultation costs require an itemized personalized quote.
When the gap closes, Defy Medical can move to In.
Read the pick
DirectMeds Not yet
Why: Its BPC-157 listing does not meet the reviewed routine commercial compounding conditions.
When the gap closes, DirectMeds can move to In.
Read the pick
DudeMeds Not yet
Why: The reviewed disclosures do not identify the pharmacy filling the selected order.
When the gap closes, DudeMeds can move to In.
Read the pick
Eden Not yet
Why: GLP-1 no-membership claims differ from recurring-membership terms.
When the gap closes, Eden can move to In.
Read the pick
EdgeRx Not yet
Why: Names Strive Pharmacy as its one pharmacy, but not which Strive site ships.
When the gap closes, EdgeRx can move to In.
Read the pick
ElitePhysiqMD Not yet
Why: Its investigational peptide catalog leaves the qualifying access pathway unclear.
When the gap closes, ElitePhysiqMD can move to In.
Read the pick
ElleS Not yet
Why: The actual dispensing site and selected payment and refund agreement need confirmation.
When the gap closes, ElleS can move to In.
Read the pick
Embody Not yet
Why: Confirm the current renewal amount and charge interval before comparing plans.
When the gap closes, Embody can move to In.
Read the pick
Enhance MD Not yet
Why: Its partner lists differ; confirm the actual dispensing pharmacy and site.
When the gap closes, Enhance MD can move to In.
Read the pick
Found Not yet
Why: Compounded treatment availability by state is not established by its insurance map.
When the gap closes, Found can move to In.
Read the pick
Fridays Not yet
Why: TRT medication is extra; GLP-1 promotional totals need a selected renewal quote.
When the gap closes, Fridays can move to In.
Read the pick
GoodLife Health Not yet
Why: Medication is billed by the pharmacy, and no monthly drug price is published.
When the gap closes, GoodLife Health can move to In.
Read the pick
HumeCare+ Not yet
Why: Introductory homepage pricing does not establish the full prepaid renewal agreement.
When the gap closes, HumeCare+ can move to In.
Read the pick
KIN Meds Not yet
Why: Starting hormone offers do not settle the selected form, testing and recurring total.
When the gap closes, KIN Meds can move to In.
Read the pick
MangoRx Not yet
Why: The TRT testing offer and laboratory costs leave the full medication renewal unclear.
When the gap closes, MangoRx can move to In.
Read the pick
MEDGm Not yet
Why: Early charges and term billing require the selected payment schedule in writing.
When the gap closes, MEDGm can move to In.
Read the pick
MEDVi Not yet
Why: Product pages contain unresolved numerical compounded-plan price fields.
When the gap closes, MEDVi can move to In.
Read the pick
Next Vial Not yet
Why: Starting offers and differing GLP-1 pages leave selected renewal charges unconfirmed.
When the gap closes, Next Vial can move to In.
Read the pick
Nova Not yet
Why: Prescribing-decline fees and medication and membership charges need clarification.
When the gap closes, Nova can move to In.
Read the pick
PeterMD Not yet
Why: Confirm the dispensing facility, current authorization and actual recurring agreement.
When the gap closes, PeterMD can move to In.
Read the pick
RNK Health Not yet
Why: Inclusive-price claims differ from terms allowing separate pharmacy fees.
When the gap closes, RNK Health can move to In.
Read the pick
Science & Co Not yet
Why: Annual headlines do not establish the selected ongoing invoice and charge interval.
When the gap closes, Science & Co can move to In.
Read the pick
SkinnyRx Not yet
Why: Current introductory GLP-1 offers do not establish the later renewal charge.
When the gap closes, SkinnyRx can move to In.
Read the pick
Sprout Health Not yet
Why: Four-week product renewal differs from monthly policy and legacy payment instructions.
When the gap closes, Sprout Health can move to In.
Read the pick
TrimRx Not yet
Why: Homepage and terms show different offers; confirm the selected payment schedule.
When the gap closes, TrimRx can move to In.
Read the pick
Tyde Wellness Not yet
Why: The exact longevity formulation and qualifying access pathway need confirmation.
When the gap closes, Tyde Wellness can move to In.
Read the pick
Wellorithm Not yet
Why: Monthly pricing and twenty-eight-day terms describe different renewal schedules.
When the gap closes, Wellorithm can move to In.
Read the pick
WePeptideRx Not yet
Why: Dose-selector prices differ from the same product page’s overview.
When the gap closes, WePeptideRx can move to In.
Read the pick

What the rules check, and what to expect

Six rules decide the list. A clinician has to review you before any prescription ships, and the cost per month must be readable before payment. A licensed US pharmacy fills orders. No research-use peptides are for sale, cancellation terms are spelled out, and the intake has to work. How picks work covers the details.

Set expectations by drug. Semaglutide and tirzepatide are FDA-approved for type 2 diabetes in their brand forms. Metformin is approved for type 2 diabetes too, but no randomized trial shows it slows aging in people without diabetes, and it can blunt gains from exercise. Rapamycin for longevity is off-label. Read what metformin is and whether metformin helps with inflammation.

How to choose between the picks

Match the diagnosis before the subscription. Diabetes treatment, weight management and an off-label aging proposal are separate clinical decisions. Ask which approved indication or off-label rationale applies to your own health history. A provider offering several medicines should explain why one is being considered instead of steering every visitor toward its largest menu. Request the proposed product name before authorizing a metabolic assessment.
Separate drug spending from access fees. A membership may pay for consultations while a different pharmacy charges for the medicine. Ask which organization receives each payment and what happens to the care fee if your preferred prescription is declined. An insurance-support service is not a promise that your insurer will cover the selected drug. Keep the coverage decision separate from permission to collect a membership payment.
Compare the commitment with the clinical plan. A low prepaid equivalent commits cash before you know whether the proposed medicine is tolerable. Obtain the unused-balance policy and identify when pharmacy processing makes an order final. Ask who manages a pause or change of treatment, because canceling future account access may not stop a prescription already being prepared. Record the financial cutoff separately from the date a shipment is expected.
Define the follow-up you actually need. Ask what the clinician will monitor for the specific medicine and why those measurements matter to your diagnosis. Also establish who reviews results, how unexpected findings are communicated and which appointments or tests cost extra. A broad longevity panel cannot substitute for a plan that connects a result with an appropriate clinical decision. Ask how your usual diabetes or primary-care clinician receives that information.

Questions about this list

How much does metformin cost through a longevity program?: Posted prices for metformin run $25–$169 a month. Rapamycin runs $65–$207 a month. GLP-1 plans cost more, and each pick card shows the provider's own figure.
Can I take metformin for longevity if I don't have diabetes?: Some programs prescribe it off-label for healthy aging. No randomized trial shows it slows aging in people without diabetes, and it may blunt the gains from exercise. Your prescriber decides whether it fits.
Can a lower-cost metabolic medicine replace the one my clinician recommends?: Price alone cannot establish a substitute. Metformin, GLP-1 medicines and off-label rapamycin do not have the same approved uses or clinical evidence. Ask what problem the proposed medicine addresses and which alternatives fit that problem. A low-cost aging offer should not be treated as equivalent to an approved diabetes or obesity treatment.
Why are GLP-1 drugs on a metabolic list?: Semaglutide and tirzepatide are approved brand drugs for type 2 diabetes, and people seek them out for blood sugar and weight. A provider selling either one can appear here and on the body-composition list.

This is general information, not medical advice. A licensed clinician can tell you what fits you. Health note